AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice
Decreased cardiac myosin-binding protein C (cMyBPC) expression due to inheritable mutations is thought to contribute to the hypertrophic cardiomyopathy (HCM) phenotype, suggesting that increasing cMyBPC content is of therapeutic benefit. In vitro assays show that cMyBPC N-terminal domains (NTDs) con...
Main Authors: | Jiayang Li, Ranganath Mamidi, Chang Yoon Doh, Joshua B. Holmes, Nikhil Bharambe, Rajesh Ramachandran, Julian E. Stelzer |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2020-09-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.130182 |
Similar Items
-
Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
by: Anna D. Cirac, et al.
Published: (2017-06-01) -
UMP dan BPC kukuh kerjasama
by: Nur Laila, Afandi
Published: (2018) -
Different Phenotypes of Sarcomeric <i>MyBPC3</i>-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis)
by: Olga Blagova, et al.
Published: (2022-07-01) -
Mixed Hypertrophic and Dilated Phenotype of Cardiomyopathy in a Patient With Homozygous In-Frame Deletion in the MyBPC3 Gene Treated as Myocarditis for a Long Time
by: Olga Blagova, et al.
Published: (2020-09-01) -
Effect of Pentadecapeptide BPC 157 on Hypercalcaemia in Rats
by: Matej Lacković, et al.
Published: (2023-01-01)